HealthDay on MSN
Expectant management matches active treatment in preemies with patent ductus arteriosus
For extremely preterm infants with protocol-defined patent ductus arteriosus (PDA), the incidence of death or ...
MONDAY, Dec. 15, 2025 (HealthDay News) — Doing nothing at all to manage a common fetal heart defect might improve the ...
Abbott Laboratories recently received U.S. FDA clearance and CE Mark for its Amplatzer Piccolo Delivery System, enabling more ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heartNew delivery system enables precise placement ...
Abbott has announced it has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its Amplatzer Piccolo ...
Watching their daughter, Mila, overcome all challenges has been Lex and David Ramirez's "greatest joy," the mom told Newsweek ...
Medical Device Network on MSN
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approval for its Amplatzer Piccolo Delivery System, ...
The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...
Abbott Laboratories is set to roll out its Volt PFA System in the U.S., following federal approval, and continue expanding ...
Abbott (NYSE: ABT) received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results